Tech Company Financing Transactions

Upstream Bio Funding Round

Upstream Bio, operating out of Waltham, secured $200 million from Maruho, OrbiMed and Access Industries.

Transaction Overview

Company Name
Announced On
6/2/2022
Transaction Type
Venture Equity
Amount
$200,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
460 Totten Pond Rd. 420
Waltham, MA 02451
USA
Phone
Undisclosed
Email Address
Overview
At Upstream Bio we strive to reach the source of inflammation and conquer it. Our lead program is a clinical-stage monoclonal antibody that inhibits the TSLP receptor. TSLP is a validated target positioned upstream of multiple signaling cascades that affect a variety of immune cells pivotal to common and rare diseases.
Profile
Upstream Bio LinkedIn Company Profile
Social Media
Upstream Bio Company Twitter Account
Company News
Upstream Bio News
Facebook
Upstream Bio on Facebook
YouTube
Upstream Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Samantha Truex
  Samantha Truex LinkedIn Profile  Samantha Truex Twitter Account  Samantha Truex News  Samantha Truex on Facebook
Chief Medical Officer
Aaron Deykin
  Aaron Deykin LinkedIn Profile  Aaron Deykin Twitter Account  Aaron Deykin News  Aaron Deykin on Facebook
Co-Founder
Oren Becker
  Oren Becker LinkedIn Profile  Oren Becker Twitter Account  Oren Becker News  Oren Becker on Facebook
VP - Bus. Development
Jen Beachell
  Jen Beachell LinkedIn Profile  Jen Beachell Twitter Account  Jen Beachell News  Jen Beachell on Facebook
VP - Bus. Development
Adam Houghton
  Adam Houghton LinkedIn Profile  Adam Houghton Twitter Account  Adam Houghton News  Adam Houghton on Facebook
VP - Finance
Robert Prentiss
  Robert Prentiss LinkedIn Profile  Robert Prentiss Twitter Account  Robert Prentiss News  Robert Prentiss on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/2/2022: ZeroNorth Denmark venture capital transaction
Next: 6/2/2022: Chainguard venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary